RxDoctor Payments Data

Katherine Schuetz, OD

Optometrist · Zionsville, INNPI 1316039803

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 88.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $4,620 and has fallen 93.1% since, to $318 in 2025. Among optometrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,088in general payments, 2019–2025

Across 77 payments — averaging $195.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$13K
  • Bausch & Lomb Americas Inc.$613
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$603
  • Alcon$296
  • Tarsus Pharmaceuticals, Inc.$125
  • Amgen$61
  • plus $65 from 3 others
$287,676in research payments, 2019–2025

Across 7 payments — averaging $41,097 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Plexus Optix, Inc.$276K
  • Coopervision Inc.$12K

What the payments were for

  • Consulting fees$8,00053%
  • Speaking & faculty fees$3,75025%
  • Travel & lodging$9046%
  • Food & beverage$2,43416%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,088 in reported general payments places this provider in the 95th percentile of 1,318 optometrist providers in Indiana.

See all optometrist providers in Indiana

Medicare billing

Part B allowed, 2024
$2,630
Medicare patients
22
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Zionsville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →